Long-Term Human Albumin Fails to Improve Survival in Decompensated Cirrhosis
(MedPage Today) — Long-term human albumin therapy failed to significantly improve long-term survival outcomes in cirrhotic patients with acute decompensation and ascites, the phase III randomized PRECIOSA trial showed.
Treatment with human albumin…
